Capricor Therapeutics (CAPR) Current Leases (2021 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly Current Leases of $841135.0 in Q1 2026, up 315.63% quarter-over-quarter from $202376.0 in Q4 2025, and little changed on a YoY basis from $842101.0 in Q1 2025.
Capricor Therapeutics (CAPR) Current Leases (2021 - 2026) Analysis & Trends
Capricor Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $841135.0 for Q1 2026.
- In Q1 2026, Current Leases changed 0.11% year-over-year to $841135.0; the TTM figure through Mar 2026 stood at $841135.0 (changed 0.11% YoY), while the FY2025 annual figure was $202376.0, down 75.76% from the prior year.
- Current Leases was $841135.0 for Q1 2026 at Capricor Therapeutics, up from $202376.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $849505.0 in Q2 2025 to a low of $120094.0 in Q3 2025.
- Historically, Current Leases has averaged $670896.8 across 5 years, with a median of $729567.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Current Leases soared 63.31% in 2022, then plunged 85.24% in 2025.
- A 5-year view of Current Leases shows it stood at $682039.0 in 2022, then gained by 9.83% to $749112.0 in 2023, then rose by 11.44% to $834799.0 in 2024, then plunged by 75.76% to $202376.0 in 2025, then soared by 315.63% to $841135.0 in 2026.
- The last three Current Leases figures came in at $841135.0 (Q1 2026), $202376.0 (Q4 2025), and $120094.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | 841,135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 841,135.00 |
| Dec 31, 2025 | 202,376.00 |
| Sep 30, 2025 | 120,094.00 |
| Jun 30, 2025 | 849,505.00 |
| Mar 31, 2025 | 842,101.00 |
| Dec 31, 2024 | 834,799.00 |
| Sep 30, 2024 | 813,634.00 |
| Jun 30, 2024 | 792,694.00 |
| Mar 31, 2024 | 771,506.00 |
| Dec 31, 2023 | 749,112.00 |
| Sep 30, 2023 | 729,567.00 |
| Jun 30, 2023 | 707,425.00 |
| Mar 31, 2023 | 693,652.00 |
| Dec 31, 2022 | 682,039.00 |
| Sep 30, 2022 | 697,561.00 |
| Jun 30, 2022 | 579,672.00 |
| Mar 31, 2022 | 498,374.00 |
| Dec 31, 2021 | 417,632.00 |